BHLHB9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.916800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.043200E-01
Normal-vs-Stage2
7.672800E-01
Normal-vs-Stage3
8.387900E-02
Normal-vs-Stage4
2.554000E-01
Stage1-vs-Stage2
1.265560E-01
Stage1-vs-Stage3
6.027600E-02
Stage1-vs-Stage4
7.061400E-01
Stage2-vs-Stage3
2.756200E-01
Stage2-vs-Stage4
2.602300E-02
Stage3-vs-Stage4
3.537700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.525800E-01
Normal-vs-AfricanAmerican
8.784200E-01
Normal-vs-Asian
3.151400E-01
Caucasian-vs-AfricanAmerican
7.917800E-01
Caucasian-vs-Asian
1.818430E-01
AfricanAmerican-vs-Asian
3.665000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.872000E-01
Normal-vs-Female
9.589600E-01
Male-vs-Female
7.882000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.578400E-01
Normal-vs-Age(41-60Yrs)
7.282400E-01
Normal-vs-Age(61-80Yrs)
8.780200E-01
Normal-vs-Age(81-100Yrs)
4.300400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.655000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.770400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.221000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.052100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.022200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.269800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.671560E-01
Normal-vs-Daily Drinker
3.686400E-01
Normal-vs-Weekly Drinker
7.587600E-01
Normal-vs-Occasional Drinker
6.086800E-01
Normal-vs-Social Drinker
7.022600E-01
Non Drinker-vs-Daily Drinker
5.058800E-01
Non Drinker-vs-Weekly Drinker
9.754200E-02
Non Drinker-vs-Occasional Drinker
1.563840E-02
Non Drinker-vs-Social Drinker
6.100300E-02
Daily Drinker-vs-Weekly Drinker
3.402000E-01
Daily Drinker-vs-Occasional Drinker
3.607700E-02
Daily Drinker-vs-Social Drinker
1.065040E-01
Weekly Drinker-vs-Occasional Drinker
1.475010E-01
Weekly Drinker-vs-Social Drinker
2.764600E-01
Occasional Drinker-vs-Social Drinker
8.920000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.195800E-01
Normal-vs-Grade 2
2.883200E-01
Normal-vs-Grade 3
2.648400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.075000E-01
Grade 1-vs-Grade 3
3.947200E-01
Grade 1-vs-Grade 4
4.195800E-01
Grade 2-vs-Grade 3
7.712400E-01
Grade 2-vs-Grade 4
2.883200E-01
Grade 3-vs-Grade 4
2.648400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.716000E-01
Normal-vs-NonDiabetic
9.538000E-01
Diabetic-vs-NonDiabetic
5.593200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.914000E-01
Normal-vs-NoPancreatitis
9.827200E-01
Pancreatitis-vs-NoPancreatitis
6.464200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.836800E-01
Normal-vs-N1
8.566600E-01
N0-vs-N1
3.325800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.101000E-01
Normal-vs-TP53-NonMutant
5.794200E-01
TP53-Mutant-vs-TP53-NonMutant
4.917900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
